Status:
COMPLETED
Metabolic Consequences of Moderate Weight Gain - Role of Dietary Fat Composition (LIPOGAIN)
Lead Sponsor:
Uppsala University
Conditions:
Healthy
Eligibility:
All Genders
20-38 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate the metabolic consequences of a moderate weight gain and if the type of dietary fat (saturated versus polyunsaturated) can modify the effects in young healt...
Detailed Description
Specific goals: * Investigate if dietary fat composition influences liver fat accumulation and metabolic risk factors in response to moderate weight gain * Investigate if polyunsaturated fat (PUFA) i...
Eligibility Criteria
Inclusion
- Healthy,
- Body Mass Index 18-27
Exclusion
- Liver disease,
- Coronary heart disease,
- Diabetes mellitus,
- Malignant diseases,
- Alcohol or drug abuse,
- Magnetic Resonance-incompatibility,
- Abnormal clinical chemistry,
- Use of drugs that significantly effects energy metabolism,
- Heavy exercise,
- Pregnancy or lactation,
- Allergy of gluten, egg or milk protein
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT01427140
Start Date
September 1 2011
End Date
December 1 2011
Last Update
December 9 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uppsala University Hospital, Uppsala Science Park
Uppsala, Sweden